306960-35-0

Upstream product

• 85026-60-4 (3R,4S,5R)-4-(benzoyloxy)-5-((benzoyloxy)methyl)tetrahydrofuran-2,3-diyl diacetate 
• 306960-30-5 4-aminopyrido[2,3-d]pyrimidin-5(8H)-one 
• 98651-70-8 2-amino-4-methoxypyridine-3-carbonitrile 
• 306960-29-2 2-amino-3-cyano-1H-pyrid-4-one 
• 376393-89-4 C₂₈H₂₄N₄O₈ 

Downstream Products

• 306960-36-1 C₂₆H₂₂N₄O₇ 
• 306960-37-2 8-{3-[bis-(4-methoxy-phenyl)-phenyl-methoxy]-5-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-oxo-tetrahydro-furan-2-yl}-4-{[bis-(4-methoxy-phenyl)-phenyl-methyl]-amino}-8H-pyrido[2,3-d]pyrimidin-5-one 
• 1053475-66-3 8-{3-[bis-(4-methoxy-phenyl)-phenyl-methoxy]-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl}-4-{[bis-(4-methoxy-phenyl)-phenyl-methyl]-amino}-8H-pyrido[2,3-d]pyrimidin-5-one 

Relevant academic research and scientific papers

Synthesis and anticancer activity of 4-amino-5-oxo-8-(β-D-xylofuranosyl) pyrido[2,3-d]pyrimidine

4-Amino-5-oxo-8-(β-D-xylofuranosyl)pyrido[2,3-d]pyrimidine (4) was recently synthesized and evaluated in our laboratories for anticancer activities. This compound showed potent in vitro inhibitory effects on the growth of HTB-81 prostate cancer cells and

Synthesis and cytotoxicity of 4-amino-5-oxopyrido[2,3-d]pyrimidine nucleosides

A number of nucleoside analogues have been either used clinically as anticancer drugs or evaluated in clinical studies, while new nucleoside analogues continue to show promise. In this article, we report synthesis and cytotoxicity of a series of new pyrid